Stoke Therapeutics, Inc. - Common Stock (STOK)

CUSIP: 86150R107

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
57,529,259
Total 13F shares
34,632,372
Share change
-315,920
Total reported value
$1,159,842,494
Price per share
$33.49
Number of holders
89
Value change
+$2,937,942
Number of buys
37
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 86150R107?
CUSIP 86150R107 identifies STOK - Stoke Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of STOK - Stoke Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ATP Life Science Ventures, L.P.
13F
Company
29%
16,786,713
$391,802,000 30 Jun 2020
13F
RTW INVESTMENTS, LP
13F
Company
6.2%
3,544,248
$84,459,000 30 Jun 2020
13F
Redmile Group, LLC
13F
Company
4.3%
2,502,306
$59,630,000 30 Jun 2020
13F
Cormorant Asset Management, LP
13F
Company
3%
1,701,292
$40,542,000 30 Jun 2020
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
2.7%
1,569,564
$37,403,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
2.2%
1,278,341
$30,462,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
2.1%
1,214,130
$28,932,000 30 Jun 2020
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
1.9%
1,119,963
$26,689,000 30 Jun 2020
13F
FEDERATED HERMES, INC.
13F
Company
1.4%
830,400
$19,788,000 30 Jun 2020
13F
FMR LLC
13F
Company
1.3%
771,866
$18,394,000 30 Jun 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
1.2%
671,978
$16,013,000 30 Jun 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.68%
391,358
$9,326,000 30 Jun 2020
13F
Artal Group S.A.
13F
Company
0.5%
285,000
$6,792,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
0.46%
267,139
$6,366,000 30 Jun 2020
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.44%
254,229
$6,058,000 30 Jun 2020
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.35%
200,000
$4,766,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
0.33%
189,960
$4,527,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.28%
159,944
$3,811,000 30 Jun 2020
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.25%
143,905
$3,429,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.25%
143,184
$3,412,000 30 Jun 2020
13F
LORD, ABBETT & CO. LLC
13F
Company
0.23%
132,728
$3,163,000 30 Jun 2020
13F
Casdin Capital, LLC
13F
Company
0.21%
120,000
$2,860,000 30 Jun 2020
13F
VICTORY CAPITAL MANAGEMENT INC
13F
Company
0.13%
77,262
$1,841,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.11%
63,891
$1,523,000 30 Jun 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.1%
56,148
$1,338,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
0.09%
51,044
$1,216,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0.09%
50,590
$1,206,000 30 Jun 2020
13F
SG Americas Securities, LLC
13F
Company
0.04%
25,280
$602,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.04%
24,700
$589,000 30 Jun 2020
13F
TD ASSET MANAGEMENT INC
13F
Company
0.04%
22,279
$531,000 30 Jun 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.04%
21,900
$522,000 30 Jun 2020
13F
Swiss National Bank
13F
Company
0.04%
21,900
$522,000 30 Jun 2020
13F
Birchview Capital, LP
13F
Company
0.03%
20,000
$477,000 30 Jun 2020
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.03%
19,500
$465,000 30 Jun 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.03%
18,420
$439,000 30 Jun 2020
13F
HighVista Strategies LLC
13F
Company
0.03%
17,734
$423,000 30 Jun 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.03%
16,877
$402,000 30 Jun 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.03%
15,448
$368,000 30 Jun 2020
13F
Athanor Capital, LP
13F
Company
0.02%
13,055
$311,000 30 Jun 2020
13F
Qube Research & Technologies Ltd
13F
Company
0.02%
12,970
$309,000 30 Jun 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.02%
11,100
$265,000 30 Jun 2020
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
10,302
$245,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
10,271
$245,000 30 Jun 2020
13F
Paloma Partners Management Co
13F
Company
0.02%
10,150
$242,000 30 Jun 2020
13F
BARCLAYS PLC
13F
Company
0.02%
9,981
$239,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
9,155
$218,000 30 Jun 2020
13F
MetLife Investment Management, LLC
13F
Company
0.01%
7,812
$186,160 30 Jun 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
7,471
$178,000 30 Jun 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
6,145
$146,000 30 Jun 2020
13F
CITIGROUP INC
13F
Company
0.01%
5,746
$137,000 30 Jun 2020
13F

Institutional Holders of Stoke Therapeutics, Inc. - Common Stock (STOK) as of Q3 2020

As of 30 Sep 2020, Stoke Therapeutics, Inc. - Common Stock (STOK) was held by 89 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,632,372 shares. The largest 10 holders included Apple Tree Partners IV, L.P., RTW INVESTMENTS, LP, Redmile Group, LLC, FMR LLC, Cormorant Asset Management, LP, GILDER GAGNON HOWE & CO LLC, VANGUARD GROUP INC, BlackRock Inc., FEDERATED HERMES, INC., and PERCEPTIVE ADVISORS LLC. This page lists 89 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
70
Q3 2020 holders
89
Holder diff
19
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .